help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on October 3, 2003, doi:10.1165/rcmb.2003-0077OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-0077OCv1
30/4/564    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mroz, R. M.
Right arrow Articles by Braszko, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mroz, R. M.
Right arrow Articles by Braszko, J. J.
American Journal of Respiratory Cell and Molecular Biology. Vol. 30, pp. 564-568, 2004
© 2004 American Thoracic Society
DOI: 10.1165/rcmb.2003-0077OC

p53 N-Terminal Ser-15~P and Ser-20~P Levels in Squamous Cell Lung Cancer after Radio/Chemotherapy

Robert M. Mroz, Adam Holownia, Elzbieta Chyczewska, Lech Chyczewski and Jan J. Braszko

Department of Pneumology, Department of Clinical Pharmacology, and Department of Clinical Molecular Biology, Bialystok Medical University, Bialystok, Poland

Address correspondence to: Dr. Robert Mroz, Department of Pneumology, Bialystok Medical University, Zurawia 14, 15-540 Bialystok, Poland. E-mail: robmroz{at}wp.pl

Functional regulation of p53 protein, a critical regulator of cell cycle and apoptosis, was investigated in fiberoptic bronchoscopy biopsy samples taken from 23 patients suffering from recurrent squamous cell lung cancer by analyzing the expression and phosphorylation status of the p53 at Ser15 and Ser20 before and after treatment with radiotherapy/cisplatin/vinorelbine. Poly(ADP-ribose) levels as a marker of cellular DNA damage, expression of wild-type and mutated p53 protein, and Ki-67 expression as a marker of proliferation was also determined. Median p53 expression increased (61% increase) after therapy. p53 phosphorylated on Ser20 was also increased by ~ 57% in radiotherapy/chemotherapy patients, and these changes correlated with Ki-67 proliferation and with elevated (by 69%; P < 0.01) poly(ADP-ribose) levels. Our data indicate that apart from changes in p53 quantity, post-translational phosphorylation/dephosphorylation-mediated alterations, especially at Ser20 may play a role in p53 stabilization and, therefore, in antiproliferative activity of drugs inducing DNA damage and apoptosis.

Abbreviations: adenosine diphosphate, ADP • bovine serum albumin, BSA • enhanced chemiluminescence, ECL • ethylenediaminetetraacetic acid, EDTA • gray, Gy • immunoglobulin G antibody, IgG Ab • left lower lobectomy, LLL • left pulmonectomy, LP • murine double minute protein, MDM2 • sodium vanadate, Na3VO4 • sodium azide, NaN3 • saponine NP-40, NP-40 • p53 protein, p53 • p53 phosphorylated on serines 15, 20, 392, Ser15~P, Ser20~P, Ser392~P • p300 protein, p300 • phenylmethylsulfonyl fluoride, PMSF • phosphate-buffered saline + Tween, PBS-T • poly(ADP-ribose), PAR • proliferation-associated nuclear antigen Ki-67, Ki-67 • right lower bilobectomy, RLB • right pulmonectomy, RP • right upper lobectomy, RUL • sodium dodecyl sulfate polyacrylamide gel electrophoresis, SDS-PAGE • tumor, node, metastasis, TNM • Western blot, WB




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
C. Jiang, H. Hu, B. Malewicz, Z. Wang, and J. Lu
Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells
Mol. Cancer Ther., July 1, 2004; 3(7): 877 - 884.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2004 American Thoracic Society.
  Tobacco